SCHEMBL3680333

SCHEMBL3680333

N#CC(=NO)c1cc(F)ccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.47
CES1 P23141 3/20 0.47
ALDH1A1 P00352 4/20 0.41
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
CA3 P07451 1/20 0.38
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
HSD17B10 Q99714 2/20 0.33
TP53 P04637 1/20 0.33
MDM2 Q00987 3/20 0.32
KEAP1 Q14145 1/20 0.32
PPME1 Q9Y570 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
HIF1A Q16665 1/20 0.30
TAS1R3 Q7RTX0 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3680330 1.00 CES2 (0.47) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL3680288 0.85 CES2 (0.47) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL3680287 0.85 CES2 (0.47) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL9823228 0.79 HPGD (0.40) ALDH1A1LMNAMAPTHTT
SCHEMBL10472439 0.77 HPGD (0.39) ALDH1A1LMNAMAPTHTTSMN1; SMN2
SCHEMBL10472437 0.77 HPGD (0.39) ALDH1A1LMNAMAPTHTT
SCHEMBL10753333 0.77 CES2 (0.43) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL10753337 0.77 CES2 (0.43) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL10752112 0.72 LMNA (0.53) CES2CES1ALDH1A1LMNAMAPT
SCHEMBL10752119 0.72 LMNA (0.53) CES2CES1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7727967-B2 Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines BOISE STATE UNIVERSITY (US) 2010-06-01 US claimed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US claimed
US-7781412-B2 Biphenyl inhibitors of carbonyl reductase BOISE STATE UNIVERSITY (US) 2010-08-24 US disclosed
US-7727967-B2 Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines BOISE STATE UNIVERSITY (US) 2010-06-01 US disclosed
WO-2009048760-A2 BIPHENYL INHIBITORS OF CARBONYL REDUCTASE BOISE STATE UNIVERSITY (US) 2009-04-16 WO disclosed
US-20080227731-A1 BIPHENYL INHIBITORS OF CARBONYL REDUCTASE BOISE STATE UNIVERSITY (US) 2008-09-18 US disclosed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US disclosed
US-20080182804-A1 CYANOOXIME INHIBITORS OF CARBONYL REDUCTASE AND METHODS OF USING SAID INHIBITORS IN TREATMENTS INVOLVING ANTHRACYCLINES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-07-31 US disclosed